Visceral obesity : the link among inflammation, hypertension, and cardiovascular disease

Authors: Mathieu, PatrickPoirier, PaulPibarot, PhilippeLemieux, IsabelleDesprés, Jean-Pierre
Abstract: The worldwide epidemic of obesity, fostered by the modern lifestyle characterized by the lack of physical activity and an energy-dense diet, has contributed to create an unprecedented condition in human history where a majority of overfed individuals will soon surpass the number of malnourished. Obesity-associated disorders, such as diabetes mellitus, an atherogenic dyslipidemia, and hypertension, have undoubtedly contributed to create an atherosclerosis-prone environment and thereby the development of cardiovascular disease (CVD), a leading cause of mortality in Westernized societies. A growing body of evidence indicates that obesity is a heterogeneous condition in which body fat distribution is closely associated with metabolic perturbations and, thus, with CVD risk. In this regard, accumulation of visceral (intra-abdominal) fat is strongly associated with insulin resistance and with a typical atherogenic dyslipidemic state. The adipose tissue, once considered a simple energy warehouse, is now regarded as a complex organ not only contributing to the management of energy flux within the body but also interacting with the inflammatory system and the vascular wall. Furthermore, recent studies have underlined that there are intricate interplays among adipocytes, the sympathetic nervous system (SNS), and the renin-angiotensin system (RAS), which participate in the obesity-associated dysmetabolic state. Thus, the adipose tissue is believed to play an important role in the development of both hypertension and other complications related to insulin resistance. However, it should be pointed out that different fat depots have distinct metabolic characteristics, leading to individual differences in the impact of obesity on cardiometabolic risk. Herein, we reviewed the complex links among visceral adiposity, inflammation, and hypertension, along with an attempt to address the clinical implications of these interactions.
Document Type: Article de recherche
Issue Date: 23 February 2009
Open Access Date: Restricted access
Document version: VoR
This document was published in: Hypertension, Vol. 53 (4), 577–584 (2009)
American Heart Association
Alternative version: 10.1161/HYPERTENSIONAHA.108.110320
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
Description SizeFormat 
546.76 kBAdobe PDF    Request a copy
All documents in CorpusUL are protected by Copyright Act of Canada.